Lipatov O Nikolaevich

Efficacy of HD201 vs Referent Trastuzumab in Patients With ERBB2-Positive Breast Cancer Treated in the Neoadjuvant Setting

G. Bonamy, M. Derde, X. Pivot, 2022, JAMA oncology.